Small Intestine Cancer
📧 Sign up to get email alerts when something new happens for Small Intestine Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer [Phase 1]
Phase 1 trial evaluating gemcitabine with radiation therapy in locally advanced upper gastrointestinal cancers, including extrahepatic bile …
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Flavopiridol in Treating Patients With Refractory Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of flavopiridol in patients with refractory cancers, including lymphoma, prostate canc…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
The entry details the completion of a Phase 1 trial evaluating Bryostatin 1 in combination with Interleukin-2 in patients with refractory so…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer [Phase 1]
Phase 1 trial evaluating the combination of oxaliplatin and capecitabine in patients with colorectal cancer, appendiceal cancer, or small in…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction [Phase 1]
Phase 1 study of ixabepilone in patients with advanced solid tumors or lymphoma (including liver dysfunction) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-08-08Clinical Trial Update: Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase II clinical trial evaluating brostallicin or doxorubicin as first-line therapy for relapsed, refractory, or metastatic soft tissue sar…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma [Phase 1]
A Phase 1 trial evaluating imetelstat in pediatric patients with refractory or recurrent solid tumors or lymphoma has completed. The update …
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas [Phase 2]
This is a completed Phase 2 trial of Nitrocamptothecin in patients with soft tissue sarcomas, including gastrointestinal stromal tumors and …
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors [Phase 2]
Phase 2 clinical trial update on combination chemotherapy for pediatric metastatic rhabdomyosarcoma and other malignant mesenchymal tumors; …
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma [Phase 2]
This is a Phase 2 trial update evaluating high-dose chemotherapy with peripheral blood stem cell transplant for intestinal T-cell lymphoma.
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma [Phase 1]
Phase 1 trial of alemtuzumab combined with chemotherapy for peripheral T-cell lymphoma (stages I–IV); current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma [Phase 3]
This document reports a Phase 3 trial update on using levofloxacin to prevent chemotherapy-related infection in patients with solid tumors o…
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus [Phase 1]
Phase 1 trial evaluating ganciclovir plus arginine butyrate in EBV-associated cancers; the study has completed.
-
CLINICAL_TRIALS withdrawal · 2013-07-24Clinical Trial Update: Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis [Phase 2, Phase 3]
This clinical trial update notes that the Phase 2/3 study of Exisulind to prevent polyps in patients with familial adenomatous polyposis has…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]
The document reports the completion of a Phase 1 trial of AMG-479 in patients with advanced solid tumors and Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
This document reports the completion of a Phase 1 study of VNP40101M in patients with advanced solid tumors or lymphomas.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Advanced or Metastatic Cancer [Phase 1]
Phase 1 study of VNP40101M in adults with advanced or metastatic cancer has completed. The sponsor is Vion Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma [Phase 1]
This clinical trial update reports completion of a Phase 1 study evaluating combination chemotherapy with or without biological therapy in p…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial update evaluating interferon alfa-2b in patients with advanced low-grade Non-Hodgkin lymphoma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy [Phase 1]
Phase 1 trial update of Suberoylanilide Hydroxamic Acid (SAHA) in adults with advanced solid tumors that failed prior therapy; the study sta…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
A Phase 1 trial evaluating ZD0473 in combination with doxorubicin in adults with advanced solid tumors or lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Pyroxamide in Treating Patients With Advanced Cancer [Phase 1]
Clinical trial update for Pyroxamide in advanced cancer: a Phase 1 study sponsored by Memorial Sloan Karger Cancer Center has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract [Phase 2]
A Phase 2 clinical trial of a cancer vaccine therapy for gastrointestinal cancers was terminated, with the study status shown as TERMINATED.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma [Phase 1]
Phase 1 trial update reporting results for a monoclonal antibody therapy in patients with advanced or recurrent lymphoma; the study status i…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis [Phase 1]
Phase 1 trial evaluating irinotecan in patients with solid tumors or lymphoma who have abnormal liver or kidney function or prior pelvic rad…